Honoring our roots, caring for our community.

FDA-approved medication · specific indications

Liraglutide: an FDA-approved GLP-1 medicine

Approved, depending on the product, for type 2 diabetes or for chronic weight management, after a medical evaluation.

Evidence-based care Individualized plan
Liraglutide

Introduction

A prescription GLP-1 medicine with specific approved uses

Liraglutide is a prescription medicine. Depending on the product, it is FDA-approved for type 2 diabetes or for chronic weight management, always together with nutrition and physical activity.

At Harmony, liraglutide is considered only after a medical evaluation of your health history, medications and goals.

Overview

What is liraglutide?

Liraglutide is a GLP-1 receptor agonist: a medicine that works like GLP-1, a hormone the gut releases after eating. It is an injectable prescription medicine.

How it works

How it acts on the GLP-1 receptor

Insulin when blood sugar is high

Helps the pancreas release insulin in response to glucose.

Less glucagon

Reduces a hormone that raises blood sugar.

Slower stomach emptying

Food leaves the stomach more slowly.

Fullness and appetite

Acts on the brain to increase fullness.

Approved uses

Approved indications by product

The products are not interchangeable. A compounded liraglutide is not the same as these FDA-approved products.

Type 2 diabetes (Victoza and its generics)

With diet and exercise, to improve blood sugar in adults and children 10 years and older with type 2 diabetes; also to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established heart disease.

Chronic weight management (Saxenda and its generics)

With a reduced-calorie diet and more physical activity, in adults with obesity, or overweight with a weight-related condition, and in some adolescents 12 and older with obesity, as defined in the label.

Next step

Talk with a provider first

Every decision about liraglutide starts with a medical evaluation by a licensed provider.

Request a medical consultation

Candidates

Candidate evaluation

An evaluation does not mean liraglutide will be prescribed.

Adults with type 2 diabetes

Reviewed with your current treatment and blood sugar.

Adults with obesity or overweight

With a weight-related condition, as the label defines.

Full health history

Including thyroid, pancreas, gallbladder and kidney history.

Safety

Contraindications and important warnings

Boxed warning: liraglutide caused thyroid C-cell tumors in rodents; it is unknown whether it causes them, including medullary thyroid carcinoma (MTC), in people. Tell your provider about a lump or swelling in the neck, trouble swallowing, shortness of breath or persistent hoarseness.

Other warnings in the labels include pancreatitis, gallbladder problems, low blood sugar when used with insulin or sulfonylureas, kidney problems from dehydration, increased heart rate, serious allergic reactions and, for weight management, suicidal thoughts. Liraglutide should not be used if any of the following apply to you:

  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • Serious allergy to liraglutide or its ingredients
  • Pregnancy (weight management)

Side effects

Common side effects

Seek urgent care for severe abdominal pain that does not go away, with or without vomiting.

Nausea

The most common, often early on.

Diarrhea or constipation

Usually improves over time.

Vomiting

Can lead to dehydration.

Headache

Usually mild.

Decreased appetite

An expected effect.

Low blood sugar

Mainly with insulin or sulfonylureas.

Follow-up

Clinical follow-up

Your provider sets the timing of each visit and test.

Response and side effects

Weight or blood sugar, and digestive symptoms.

Blood sugar and A1C, when indicated

Especially with other diabetes medicines.

Kidney function, when indicated

For example after vomiting or dehydration.

Mood

Any new or worsening depression is reviewed.

Need to continue

Treatment is reassessed if the benefit is not clear.

FAQ

Liraglutide FAQs

Clear answers to help you prepare.

Yes, for specific uses: Victoza and its generics for type 2 diabetes, and Saxenda and its generics for chronic weight management. Each product has its own approved indications.

No. Compounded drugs are not FDA-approved, and the FDA does not review their safety, effectiveness or quality before they are sold.

It must not be used with a personal or family history of medullary thyroid carcinoma or with MEN 2. Tell your provider about any thyroid cancer in your family.

They are related medicines with different products, approvals and schedules. Your provider explains which option, if any, fits you.

Any medicine, dose, route and schedule are decided only by a licensed provider after an individual evaluation. This page is educational and does not give treatment instructions.

Information on this page is educational and does not replace medical evaluation. Treatment options are determined individually.